← Back to Search

Physical Activity Pathway for Osteoarthritis (OA-PCP Trial)

N/A
Waitlist Available
Led By Kelli D Allen, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Current Joint Symptoms
Self-reported physical activity <150 minutes per week
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 12 (follow-up)
Awards & highlights

OA-PCP Trial Summary

This trial will test an osteoarthritis care pathway that includes physical activity screening and counseling in primary care, referral to community programs, and follow-up with patients.

OA-PCP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are currently experiencing joint pain or discomfort.
Select...
You do less than 2.5 hours of physical activity every week.

OA-PCP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 12 (follow-up)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 12 (follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change From Baseline to Month 12 for Minutes in Objectively Assessed Physical Activity (accelerometer)
Change From Baseline to Month 6 in Objectively Assessed Physical Activity (accelerometer)
Secondary outcome measures
Change From Baseline to Month 12 for Minutes of Sedentary Activity
Change From Baseline to Month 12 for Steps Per Day
Change From Baseline to Month 12 in Western Ontario and McMasters Universities Osteoarthritis (WOMAC) Function Subscale
+5 more

OA-PCP Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: OA-PCPExperimental Treatment1 Intervention
Participants assigned to the OA-PCP intervention will receive an initial physical activity (PA) coaching call then, 5 more calls over the course of 12 months. Participants, if they agree, will also receive monthly check-in emails between phone calls.
Group II: Attention ControlPlacebo Group1 Intervention
Participants assigned to the Attention Control group will receive the same number of phone calls over the course of 12 months, focused on understanding osteoarthritis (OA) and current information on treatment options. Participants, if they agree, will also receive monthly check-in emails between phone calls.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OA-PCP Intervention
2020
N/A
~300

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,498 Previous Clinical Trials
4,175,921 Total Patients Enrolled
24 Trials studying Osteoarthritis
1,634 Patients Enrolled for Osteoarthritis
National Institutes of Health (NIH)NIH
2,679 Previous Clinical Trials
6,910,391 Total Patients Enrolled
20 Trials studying Osteoarthritis
4,577 Patients Enrolled for Osteoarthritis
National Institute on Aging (NIA)NIH
1,655 Previous Clinical Trials
28,003,879 Total Patients Enrolled
29 Trials studying Osteoarthritis
9,717 Patients Enrolled for Osteoarthritis

Media Library

OA-PCP Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04533711 — N/A
Osteoarthritis Research Study Groups: OA-PCP, Attention Control
Osteoarthritis Clinical Trial 2023: OA-PCP Intervention Highlights & Side Effects. Trial Name: NCT04533711 — N/A
OA-PCP Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04533711 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the essential aim of this clinical experiment?

"The primary purpose of this research is to assess the Change From Baseline to Month 12 for Minutes in Objectively Assessed Physical Activity. Other objectives include an examination of Change From Baseline to Month 12/6 for Steps Per Day, as well as a review of Change From Baseline to Month 6 for Moments of Sedentary Action."

Answered by AI

Is the opportunity to participate in this experiment still available for patients?

"According to clinicaltrials.gov, this study is not presently recruiting patients; the research was published on November 30th 2020 and amended most recently on September 13th 2022. Concurrently, there are 613 other studies that are actively enrolling participants for their trials."

Answered by AI
~68 spots leftby Mar 2025